We're developing innovative treatments for Alzheimer's disease.

Our Science

IP

App. : Application,

Reg. : Registration

No. Title of invention Applicant App./Reg. App. number
(Reg. number)
App. date
(Reg. date)
1 New peptide and pharmaceutical composition containing the same Amyloid Solution Inc KR App. 10-2018-0147036 2018.11.29
2 Pharmaceutical composition for treatment of neurodegenerative brain disease comprising triflupromazine or pharmaceutically acceptable salt thereof as an active ingredient Amyloid Solution Inc KR Reg. 10-2019-0102680
(10-2051624)
2019.08.21
(2019.11.26)
3 Pharmaceutical composition for treatment of neurodegenerative brain disease comprising rifamycin or pharmaceutically acceptable salt thereof as an active ingredient Amyloid Solution Inc KR Reg. 10-2019-0152592
(10-2081785)
2019.11.25
(2020.02.20)
4 Therapeutic composition and treatment method for amyloid neurological diseases Amyloid Solution Inc PCT App. PCT/KR2019/016599 2019.11.28
5 Composition for Treatment of Alzheimer's Disease comprising N402(Tentative) Activator as Active Ingredient Amyloid Solution Inc KR App. undisclosed undisclosed
6 Composition and method for treatment of amyloid cranial neuropathy Amyloid Solution Inc US App. undisclosed undisclosed
7 Pharmaceutical composition for treatment of neurodegenerative brain disease comprising rifamycin or pharmaceutically acceptable salt thereof as an active ingredient Amyloid Solution Inc KR App. undisclosed undisclosed
8 Pharmaceutical composition for treatment of
neurodegenerative brain disease comprising compound
increasing amyloid-β phagocytosis of glia as an active
ingredient
Amyloid Solution Inc KR App. undisclosed undisclosed
9 Pharmaceutical composition for treatment of
neurodegenerative brain disease comprising
N403(Tentative) as an active ingredient
Amyloid Solution Inc KR App. undisclosed undisclosed
10 Composition for Treatment of Alzheimer's Disease comprising N402(Tentative) Activator as Active Ingredient Amyloid Solution Inc PCT App. undisclosed undisclosed